Medical/Pharmaceuticals

Zhaoke Ophthalmology's Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint

Largest Ever Completed Dry Eye Disease (DED) clinical trial to date in China Zhaoke Ophthalmology's in-house developed innovative drug candidate Targeting NDA Filing by the End of 2021 Dry Eye Disease Affects Over 200 Million People in China Potential to become new standard of care for moderate-to-s...

2021-08-19 12:43 4509

MedAlliance Announces Enrollment of First Patient in Erectile Dysfunction Feasibility Study with Sirolimus Drug-Eluting Balloon

NYON, Switzerland, Aug. 19, 2021 /PRNewswire/ -- MedAlliance has announced enrollment of the first patient in an erectile dysfunction (ED) feasibility study with its sirolimus drug-eluting balloon [DEB]. This occurred at the University of Rome Tor Vergata,Italy, under the direction of the study's...

2021-08-19 08:00 3903

MicroConstants to Join BioAgilytix Family

Highly complementary transaction strengthens BioAgilytix's ability to support bioanalytical services across all major therapeutics in development; adds LC/MS/MS capabilities; and expands team of seasoned scientists DURHAM, N.C., Aug. 19, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), ...

2021-08-19 02:30 2212

BioCheck Inc Acquires DRG International Inc, a leading IVD company

Transformative deal significantly increases IVD development, manufacturing and sales channel for novel ELISA andChemiluminescent immunoassay platforms SOUTH SAN FRANCISCO, Calif., Aug. 19, 2021 /PRNewswire/ -- BioCheck, Inc. has announced that it has acquired DRG International, a leading manufac...

2021-08-19 00:04 3357

Sai Life Sciences opens new Discovery Biology facility at its integrated R&D campus in Hyderabad, India

HYDERABAD, India, Aug. 18, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the opening of a newbiology facility

2021-08-18 20:20 4305

HistoIndex's Stain-free AI-based Digital Pathology Incorporated as Secondary and Exploratory Efficacy Endpoints in Sagimet's NASH FASCINATE-2 Phase 2b Clinical Trial

SINGAPORE, Aug. 18, 2021 /PRNewswire/ -- HistoIndex , a global leading artificial intelligence (AI) digital pathology provider, has announced an agreement with clinical-stage biotechnology company Sagimet Biosciences. HistoIndex's integrated suite of stain-free imagi...

2021-08-18 18:00 2216

Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY

-  Revenue of KRW 303.7 billion ($269.1 million) is record for second quarter, up 11 percent year-over-year -  1H'21 Revenue at KRW 655.5 billion ($580.8 million), 58 percent achievement based on total sales in FY2020 -  Favorable market conditions expected in second half amid an increasing dem...

2021-08-18 18:00 2227

Perkbox reimagines global reward and benefits for the post-pandemic world

LONDON, Aug. 18, 2021 /PRNewswire/ -- Perkbox , the global benefits and reward platform, today announces its new offering to help employers care for, connect with, and celebrate their people around the world. The new location agnostic Perkbox platform enables employers...

2021-08-18 15:00 2905

H3C Joins Hands with Medical Corporation Sapporo Heart Center, Sapporo Cardio Vascular Clinic: Reshaping Digital Architecture to Embrace Smart Healthcare

SAPPORO, Japan, Aug. 18, 2021 /PRNewswire/ -- As one of the countries with the longest life expectancy in the world, the health of Japanese comes not only from good living habits, but also from high-quality medical services. Founded in 2008, Medical Corporation Sapporo Heart Center, Sapporo Cardi...

2021-08-18 11:11 3090

COVID-19 CARE Assist & Employer Tracking Programme Launched by DoctorOnCall

KUALA LUMPUR, Malaysia, Aug. 18, 2021 /PRNewswire/ -- DoctorOnCall, Malaysia's first and largest digital health platform today announced the launch of the DoctorOnCall Covid-19 CARE Assist programme for all purchasers of the Rapid Antigen (RTK-Ag) Self-Test kits. This benefit is available to A...

2021-08-18 10:00 3763

Transcenta Held Investigator Meeting and Initiated Phase IIa Clinical Trial of Claudin18.2 Monoclonal Antibody TST001 with First Patient Dosed Successfully

SUZHOU, China, Aug. 18, 2021 /PRNewswire/ -- Transcenta announced that it held an investigator meeting successfully for TST001 Phase I clinical trial study on August 14. Professors Lin Shen and Jifang Gong from Beijing Cancer Hospital, ProfessorWeijian Guo from Fudan University Shanghai Cancer Cen...

2021-08-18 08:00 2861

Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in Chinese Participants with Overweight or Obesity Published in EClinicalMedicine by the Lancet

SAN FRANCISCO and SUZHOU, China, Aug. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-08-18 08:00 4926

PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021

JAKARTA, Indonesia, Aug. 17, 2021 /PRNewswire/ -- PT Anugerah Pharmindo Lestari (APL), a member of Zuellig Pharma, a leading healthcare services company in Indonesia, has been awarded with the 'Community Initiative' and 'Outstanding Leader inAsia' for APL's President Director, Christophe Piganiol,...

2021-08-17 22:02 3672

MediTrust Health Raises Over RMB2 Billion in Series C Financing Successfully: ESG Drives Value Creation

HONG KONG, Aug. 17, 2021 /PRNewswire/ -- Shanghai MediTrust Health Technology Co., Ltd. (hereinafter referred to as "MediTrust"), a leading innovative healthcare services platform inChina, announced a successful capital raising of overRMB2 billion (approximately US$308 million) in a Series C fina...

2021-08-17 19:47 2706

Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China

HANGZHOU, China and ROCKVILLE, Md., Aug. 17, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), a biopharmaceutical innovation and partnership company, today announces that it has opened a new Advanced Cell and Gene Therapy Development Facility inHangzhou, China. Analytical development...

2021-08-17 19:00 2875

SINOMED announces the first commercial implantation and European launch of the HT Supreme Drug Eluting Stent

TIANJIN, China, Aug. 17, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced the first commercial implantation of the HT Supreme® Drug-Eluting Stent (DES) at University Hospital Galway in partnership with theNational University of Ireland Galway (NUI Galway), m...

2021-08-17 18:00 3024

MILVIK Launches COVID-19 Insurance and Telemedicine Bundle in Bangladesh

DHAKA, Bangladesh, Aug. 17, 2021 /PRNewswire/ -- Global healthcare and insurtech providerMILVIK today announces the launch of its dedicated COVID-19 bundle to consumers inBangladesh. 10-year-old MILVIK (glo...

2021-08-17 10:00 3850

Under the Patronage of His Highness Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Abu Dhabi Early Childhood Authority's WED Movement Engages Global Experts to Drive Innovation, Excellence in Early Childhood Development

ABU DHABI, UAE, Aug. 17, 2021 /PRNewswire/ -- Abu Dhabi's World Early Childhood Development Movement (WED Movement) has launched a new initiative bringing together global experts to develop innovative and actionable solutions advancing Abu Dhabi's vision to be a leader in Early Childhood Developme...

2021-08-17 00:51 4233

Tikomed's ILB® attenuates clinical symptoms and serum biomarkers of oxidative/nitrosative stress and mitochondrial dysfunction in ALS patients, data published by the Journal of Personalized Medicine

VIKEN, Sweden, Aug. 16, 2021 /PRNewswire/ -- New study results for Tikomed's platform lead drug candidate ILB® in the treatment of patients with amyotrophic lateral sclerosis (ALS), have now been published in the Journal of Personalized Medicine. The data revealed a significant normalization of t...

2021-08-16 22:32 1892

InferVision AI Assists the European Commission Monitoring COVID-19 Variants

WIESBADEN, Germany, Aug. 16, 2021 /PRNewswire/ -- InferVision AI has been selected to help monitor COVID-19 variants across the European Union. Faced with this challenge, the European Commission decided to increase their investment in the adoption of AI tools from InferVision. InferVision's AI to...

2021-08-16 21:51 4788
1 ... 366367368369370371372 ... 392